Pharmacovigilance and Drug Safety Software

23 reactions | Signals of adverse drug reactions can be based on different study designs, including clinical trials, observational studies, meta-analyses, and case reports. Daniele Sartori, #pharmacovigilance scientist at UMC, sat down in the Research Corner to discuss his recent scoping review and shine a light on the evidence base and features of ADR reports.  Access the report for further reading: doi.org/10.1007/s40264-022-01258-0 | Uppsala Monitoring Centre | Facebook